Cargando…
Immune Mechanisms of Resistance to Cediranib in Ovarian Cancer
This article investigates mechanisms of resistance to the VEGF receptor inhibitor cediranib in high-grade serous ovarian cancer (HGSOC), and defines rational combination therapies. We used three different syngeneic orthotopic mouse HGSOC models that replicated the human tumor microenvironment (TME)....
Autores principales: | Gopinathan, Ganga, Berlato, Chiara, Lakhani, Anissa, Szabova, Ludmila, Pegrum, Colin, Pedrosa, Ana-Rita, Laforets, Florian, Maniati, Eleni, Balkwill, Frances R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167758/ https://www.ncbi.nlm.nih.gov/pubmed/35313341 http://dx.doi.org/10.1158/1535-7163.MCT-21-0689 |
Ejemplares similares
-
Mouse Ovarian Cancer Models Recapitulate the Human Tumor Microenvironment and Patient Response to Treatment
por: Maniati, Eleni, et al.
Publicado: (2020) -
NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition
por: Llaurado Fernandez, Marta, et al.
Publicado: (2022) -
HER2 Mediates PSMA/mGluR1-Driven Resistance to the DS-7423 Dual PI3K/mTOR Inhibitor in PTEN Wild-type Prostate Cancer Models
por: Gómez, Valentí, et al.
Publicado: (2022) -
Optimal Strategy and Benefit of Pulsed Therapy Depend On Tumor Heterogeneity and Aggressiveness at Time of Treatment Initiation
por: Mathur, Deepti, et al.
Publicado: (2022) -
Overcoming Gemcitabine Resistance in Pancreatic Cancer Using the BCL-X(L)–Specific Degrader DT2216
por: Thummuri, Dinesh, et al.
Publicado: (2022)